An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Acquiring Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some experts stated the popularity for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.
Service Response and Material Elimination
Based on the social media company, the platform has taken down violative content and banned related hashtags and query recommendations. The organization said it was committed to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, populated with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home.
After minutes of joining one community, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.
Item Details and Costs
Inside these communities, posts display black plastic packages with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her team has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to possibly serious health risks”.
